7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Børset M et al. | Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. | 2000 | Blood | pmid:11001907 |
Terpos E et al. | Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. | 2003 | Blood | pmid:12689925 |
Zheng B et al. | MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. | 2003 | Blood | pmid:12689928 |
Kastritis E et al. | Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. | 2015 | Blood Cancer J | pmid:26047389 |
Nihrane A et al. | Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. | 2009 Jan-Feb | Blood Cells Mol. Dis. | pmid:19014892 |
Brändström H et al. | A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). | 2004 | Blood Press. | pmid:15223723 |
Tsirpanlis G | Is inflammation the link between atherosclerosis and vascular calcification in chronic kidney disease? | 2007 | Blood Purif. | pmid:17261926 |
Cianciolo G et al. | Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? | 2010 | Blood Purif. | pmid:19816015 |
Cozzolino M | Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kappaB in the vascular system. | 2009 | Blood Purif. | pmid:19729903 |
Lee JH et al. | Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis. | 2011 | BMB Rep | pmid:21777519 |
Narita N et al. | A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer. | 2008 | BMC Cancer | pmid:18684318 |
Goswami S and Sharma-Walia N | Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. | 2015 | BMC Cancer | pmid:26608463 |
Ney JT et al. | Genetic polymorphism of the OPG gene associated with breast cancer. | 2013 | BMC Cancer | pmid:23369128 |
Niu Y et al. | Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes. | 2015 | BMC Cardiovasc Disord | pmid:26260869 |
Sponder M et al. | Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. | 2017 | BMC Cardiovasc Disord | pmid:28056805 |
Nagy EE et al. | High circulating osteoprotegerin levels are associated with non-zero blood groups. | 2016 | BMC Cardiovasc Disord | pmid:27387019 |
Liu M et al. | Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. | 2013 | BMC Complement Altern Med | pmid:23782721 |
Fathilah SN et al. | Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model. | 2013 | BMC Complement Altern Med | pmid:24007208 |
Wei CC et al. | Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis. | 2013 | BMC Complement Altern Med | pmid:23870279 |
Shen Y et al. | (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. | 2015 | BMC Complement Altern Med | pmid:25887296 |
Shuid AN et al. | Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. | 2012 | BMC Complement Altern Med | pmid:22967165 |
Niu Y et al. | Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. | 2015 | BMC Endocr Disord | pmid:26626139 |
Fortner RT et al. | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. | 2017 | BMC Med | pmid:28173834 |
Piedra M et al. | "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". | 2011 | BMC Med. Genet. | pmid:22185226 |
Kulcsar-Jakab E et al. | Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. | 2015 | BMC Musculoskelet Disord | pmid:26311162 |
Kauther MD et al. | Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis. | 2011 | BMC Musculoskelet Disord | pmid:21843355 |
Kim CH et al. | Effects of high frequency loading on RANKL and OPG mRNA expression in ST-2 murine stromal cells. | 2009 | BMC Musculoskelet Disord | pmid:19728893 |
Evans CE et al. | Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK. | 2006 | BMC Musculoskelet Disord | pmid:16519799 |
Lv Y et al. | Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. | 2014 | BMC Musculoskelet Disord | pmid:25377946 |
Ma J et al. | Up-regulation of multiple proteins and biological processes during maxillary expansion in rats. | 2008 | BMC Musculoskelet Disord | pmid:18366685 |
Zhou DA et al. | Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. | 2014 | BMC Musculoskelet Disord | pmid:25027542 |
Taylan A et al. | Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. | 2012 | BMC Musculoskelet Disord | pmid:23025387 |
Pateinakis P et al. | Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. | 2013 | BMC Nephrol | pmid:23758931 |
Janda K et al. | Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. | 2015 | BMC Nephrol | pmid:26037625 |
Rzepka R et al. | Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. | 2015 | BMC Pregnancy Childbirth | pmid:26059227 |
Jiang H et al. | A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. | 2013 | BMC Pregnancy Childbirth | pmid:24321402 |
Duan P et al. | Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. | 2015 | BMC Womens Health | pmid:25884698 |
Pivonka P et al. | Model structure and control of bone remodeling: a theoretical study. | 2008 | Bone | pmid:18514606 |
Machado do Reis L et al. | Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice. | 2008 | Bone | pmid:18499553 |
Asaba Y et al. | Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption. | 2006 | Bone | pmid:16942925 |
Kanzaki S et al. | Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin. | 2006 | Bone | pmid:16564235 |
Maddi A et al. | Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells. | 2006 | Bone | pmid:16567138 |
O'Connor RD et al. | Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. | 2009 | Bone | pmid:19414073 |
O'Brien EA et al. | Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. | 2001 | Bone | pmid:11182380 |
Bendre MS et al. | Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. | 2003 | Bone | pmid:12919697 |
Ralston SH | Pathogenesis of Paget's disease of bone. | 2008 | Bone | pmid:18672105 |
Canon J et al. | Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis. | 2010 | Bone | pmid:20215062 |
Verdrengh M et al. | RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. | 2010 | Bone | pmid:19879986 |
Zhang Y et al. | Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet. | 2009 | Bone | pmid:18848653 |
Gruber R et al. | Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. | 2002 | Bone | pmid:11996911 |
Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. | 2000 | Bone | pmid:11113385 | |
Silva HC et al. | Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. | 2013 | Bone | pmid:23142805 |
Kanematsu M et al. | Vector-averaged gravity regulates gene expression of receptor activator of NF-kappaB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway. | 2002 | Bone | pmid:11934645 |
Li X et al. | Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. | 2002 | Bone | pmid:11934647 |
Ueland T et al. | No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. | 2007 | Bone | pmid:16949901 |
Kostenuik PJ et al. | Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. | 2004 | Bone | pmid:15050896 |
Brage M et al. | Osteoclastogenesis is decreased by cysteine proteinase inhibitors. | 2004 | Bone | pmid:15003789 |
El-Hoss J et al. | Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). | 2014 | Bone | pmid:24269278 |
Sasaki N et al. | Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. | 2002 | Bone | pmid:12052453 |
Wang QP et al. | Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. | 2012 | Bone | pmid:22634178 |
Wang FS et al. | Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. | 2007 | Bone | pmid:17055793 |
Humphrey EL et al. | Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. | 2006 | Bone | pmid:16298558 |
Xu M et al. | Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. | 2010 | Bone | pmid:20471507 |
Horowitz MC et al. | How B cells influence bone biology in health and disease. | 2010 | Bone | pmid:20601290 |
Uemura H et al. | Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover. | 2003 | Bone | pmid:14623063 |
Pobeha P et al. | Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. | 2011 | Bone | pmid:21376149 |
Ostrowska Z et al. | RANKL/RANK/OPG system and bone status in females with anorexia nervosa. | 2012 | Bone | pmid:22001124 |
Saidenberg-Kermanac'h N et al. | TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. | 2004 | Bone | pmid:15542046 |
Nagata N et al. | Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. | 2003 | Bone | pmid:14555278 |
Bord S et al. | The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. | 2003 | Bone | pmid:12633785 |
Reginster JY et al. | Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. | 2012 | Bone | pmid:22270053 |
Wada N et al. | Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. | 2004 | Bone | pmid:15336598 |
Kacena MA et al. | Megakaryocyte-mediated inhibition of osteoclast development. | 2006 | Bone | pmid:16782418 |
Amato G et al. | High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. | 2004 | Bone | pmid:15336617 |
Bataille C et al. | Different sympathetic pathways control the metabolism of distinct bone envelopes. | 2012 | Bone | pmid:22326888 |
Wuyts W et al. | Evaluation of the role of RANK and OPG genes in Paget's disease of bone. | 2001 | Bone | pmid:11165949 |
Nagae M et al. | Osteoclasts play a part in pain due to the inflammation adjacent to bone. | 2006 | Bone | pmid:16769263 |
Shin HH et al. | Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. | 2006 | Bone | pmid:16750437 |
Kiviranta R et al. | Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. | 2005 | Bone | pmid:15664014 |
Tat SK et al. | OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation. | 2006 | Bone | pmid:16750945 |
Mulcahy LE et al. | RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. | 2011 | Bone | pmid:20854946 |
Aspenberg P et al. | Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. | 2011 | Bone | pmid:20858557 |
Stilgren LS et al. | Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. | 2004 | Bone | pmid:15207766 |
Tsangari H et al. | Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. | 2004 | Bone | pmid:15207775 |
Valenta A et al. | Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats. | 2005 | Bone | pmid:15869920 |
Fukushima H et al. | IL-1-induced receptor activator of NF-kappa B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production. | 2005 | Bone | pmid:15780952 |
Regmi A et al. | Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation. | 2005 | Bone | pmid:15780954 |
Abrahamsen B et al. | Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins. | 2005 | Bone | pmid:15781001 |
Dunn MD et al. | Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement. | 2007 | Bone | pmid:17588510 |
Balga R et al. | Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. | 2006 | Bone | pmid:16580896 |
Bord S et al. | Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. | 2005 | Bone | pmid:15794927 |
Franklin M et al. | Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. | 2006 | Bone | pmid:16890505 |
Li X et al. | Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin. | 2009 | Bone | pmid:19539794 |
Romas E et al. | Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. | 2002 | Bone | pmid:11856640 |
Fahrleitner A et al. | Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. | 2003 | Bone | pmid:12584041 |
Martini G et al. | Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. | 2007 | Bone | pmid:16979395 |
Jacquin C et al. | Macrophage migration inhibitory factor inhibits osteoclastogenesis. | 2009 | Bone | pmid:19591967 |
Atkins GJ et al. | Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. | 2001 | Bone | pmid:11336917 |
Komine M et al. | Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. | 2001 | Bone | pmid:11344046 |
Itonaga I et al. | Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. | 2004 | Bone | pmid:14751563 |